Journal of Nanomaterials / 2013 / Article / Tab 1

Research Article

Development for High-Accuracy In Vitro Assay of Vascular Endothelial Growth Factor Using Nanomagnetically Labeled Immunoassay

Table 1

Clinical cut-off concentrations and used concentrations in this work for interference tests due to hemoglobin (Hb), conjugated bilirubin (C-BL), triglyceride (TG), alpha-fetoprotein (AFP), and carcinoembryonic antigen (CEA).

DiseaseHemolysisJaundiceHypertriglyceridemiaHepatocellular carcinomaColorectal cancer

Biomarker (as interfering material)HbC-BLTGAFPCEA
Cut-off concentration500 μg/mL2 μg/mL1500 μg/mL20 ng/mL5 ng/mL
Concentration used for interference test1000 μg/mL10 μg/mL2000 μg/mL100 ng/mL10 ng/mL

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.